Compounded imiquimod 5% ointment may be safe and effective for diffuse conjunctival melanoma in situ (MIS) or ocular surface squamous neoplasia (OSSN), according to a case series study published online Nov. 26 in JAMA Ophthalmology.
Continue Reading this article here
